This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Imai, Y.
Right arrow Articles by Margolis, T. P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imai, Y.
Right arrow Articles by Margolis, T. P.

 Previous Article  |  Next Article 

Journal of Virology, August 2009, p. 7873-7882, Vol. 83, No. 16
0022-538X/09/$08.00+0     doi:10.1128/JVI.00043-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Investigation of the Mechanism by Which Herpes Simplex Virus Type 1 LAT Sequences Modulate Preferential Establishment of Latent Infection in Mouse Trigeminal Ganglia{triangledown}

Yumi Imai,1 Kathleen Apakupakul,1 Philip R. Krause,2 William P. Halford,3 and Todd P. Margolis1,4*

F. I. Proctor Foundation, University of California at San Francisco, San Francisco, California,1 Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland,2 Department of Microbiology and Immunology, Southern Illinois University, School of Medicine, Springfield, Illinois,3 Department of Ophthalmology, University of California at San Francisco, San Francisco, California4

Received 8 January 2009/ Accepted 29 May 2009

We previously demonstrated that herpes simplex virus type 1 (HSV-1) preferentially establishes latent infection in monoclonal antibody (MAb) A5-positive ganglionic neurons and that a 2.8-kb portion of the HSV-1 genome, corresponding to the 5' end of the LAT (latency-associated transcript) coding region, is responsible for this phenotype (38, 65). In the current study we carried out further genetic mapping of this latency phenotype and investigated some of the mechanisms that might be responsible. Studies with the chimeric virus HSV-1 17syn+/LAT2, an HSV-1 virus engineered to express HSV-2 LAT, demonstrated that this virus exhibited an HSV-2 latency phenotype, preferentially establishing latency in MAb KH10-positive neurons. This result is complementary to that previously described for the chimeric virus HSV-2 333/LAT1 and indicate that the HSV-1 latency phenotype can be changed to that of HSV-2 by substitution of a 2.8-kb piece of complementary viral DNA. Sequential studies in which we evaluated the pattern of HSV-1 latent infection of the mouse trigeminal ganglion following ocular inoculation with viruses with deletions of functional thymidine kinase, glycoprotein E, ICP0, and US9 protein demonstrate that preferential establishment of HSV-1 latent infection in A5-positive neurons is not a consequence of (i) differential access of HSV-1 to A5-positive neurons,(ii) differential cell-to-cell spread of HSV-1 to A5-positive neurons, (iii) differential "round-trip" spread of HSV-1 to A5-positive neurons, or (iv) expression of ICP0. Additional mapping studies with the HSV-1 LAT deletion viruses dLAT371, 17{Delta}Sty, and 17{Delta}348 indicate that most of the LAT 5' exon is not required for HSV-1 to preferentially establish latent infection in A5-positive neurons.


* Corresponding author. Mailing address: Department of Ophthalmology, University of California at San Francisco, Medical Sciences Building, S-310, 513 Parnassus Ave., San Francisco, CA 94143-0412. Phone: (415) 476-4419. Fax: (415) 476-0527. E-mail: todd.margolis{at}ucsf.edu

{triangledown} Published ahead of print on 3 June 2009.


Journal of Virology, August 2009, p. 7873-7882, Vol. 83, No. 16
0022-538X/09/$08.00+0     doi:10.1128/JVI.00043-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.